These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 10404696

  • 1. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A.
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [Abstract] [Full Text] [Related]

  • 2. [Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis].
    Kacso I, Gherman M, Mazouz H, Ghazali A, el Esper N, Morinière P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A.
    Nephrologie; 1999 Jun; 20(1):19-28. PubMed ID: 10081033
    [Abstract] [Full Text] [Related]

  • 3. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.
    Jungers P, Hannedouche T, Itakura Y, Albouze G, Descamps-Latscha B, Man NK.
    Nephrol Dial Transplant; 1995 Jun; 10(8):1353-60. PubMed ID: 8538926
    [Abstract] [Full Text] [Related]

  • 4. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jun; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 5. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L.
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [Abstract] [Full Text] [Related]

  • 6. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
    Williams PS, Fass G, Bone JM.
    Q J Med; 1988 Apr; 67(252):343-54. PubMed ID: 3205906
    [Abstract] [Full Text] [Related]

  • 7. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 8. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu, Medvedeva TIu, Kozlovskaia NL, Miroshnichenko NG, Okonova EB, Shonichev DG, Rudenko TE, Stavrovskaia EV, Plieva OK.
    Ter Arkh; 2001 Sep; 73(6):55-61. PubMed ID: 11521525
    [Abstract] [Full Text] [Related]

  • 9. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.
    Williams PS, Stevens ME, Fass G, Irons L, Bone JM.
    Q J Med; 1991 Oct; 81(294):837-55. PubMed ID: 1801057
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group.
    Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A, Marcelli D, Francucci BM.
    Miner Electrolyte Metab; 1992 Oct; 18(2-5):295-302. PubMed ID: 1465079
    [Abstract] [Full Text] [Related]

  • 11. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Oct; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 12. Factors affecting progression in advanced chronic renal failure.
    Hannedouche T, Chauveau P, Kalou F, Albouze G, Lacour B, Jungers P.
    Clin Nephrol; 1993 Jun; 39(6):312-20. PubMed ID: 8334758
    [Abstract] [Full Text] [Related]

  • 13. Natural history of chronic renal failure: a reappraisal.
    Wight JP, Salzano S, Brown CB, el Nahas AM.
    Nephrol Dial Transplant; 1992 Jun; 7(5):379-83. PubMed ID: 1321371
    [Abstract] [Full Text] [Related]

  • 14. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA, Materson BJ, Reda DJ, Hamburger RJ, Williams DW, Smith MH.
    Clin Nephrol; 1997 May; 47(5):310-5. PubMed ID: 9181278
    [Abstract] [Full Text] [Related]

  • 15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 May; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 16. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 May; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 17. Impact of initial blood pressure on the mortality of diabetics undergoing renal replacement therapy.
    Abderrahim E, Zouaghi K, Kheder A, Cherif M, Boubaker K, Mahfoudhi M, Hedri H, Ounissi M, Ben Hamida F, Ben Moussa F, Ben Abdallah T, El Younsi F, Kâaroud H, Béji S, Goucha R, Ben Maïz H.
    Transplant Proc; 2004 May; 36(6):1820-3. PubMed ID: 15350486
    [Abstract] [Full Text] [Related]

  • 18. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [Abstract] [Full Text] [Related]

  • 19. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P, Nguyen H, Combe C, Chêne G, Azar R, Cano N, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M, French Study Group for Nutrition in Dialysis.
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [Abstract] [Full Text] [Related]

  • 20. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K, Kinjo K, Iseki C, Takishita S.
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.